Fibrinogen Signal Transduction as a Mediator and Therapeutic Target in Inflammation:Lessons from Multiple Sclerosis

E-ISSN： 1875-533x|14|27|2925-2936

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.27, 2007-11, pp. : 2925-2936

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2631-2644

Bentham Science Publishers

Access to resources Recommend Favorite

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

By Rangaraju Srikant Chi Victor Pennington Michael W Chandy K George

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 8, 2009-08 ,pp. : 909-924

Informa Healthcare

Access to resources Recommend Favorite

NF-#954;B, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 6, 2008-12 ,pp. : 536-557

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic developments in multiple sclerosis

By Goodin D.S.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 655-670

Informa Healthcare

Access to resources Recommend Favorite

Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 297-304

Bentham Science Publishers

Access to resources Recommend Favorite